|
| |
| | | 61249 | | 02.06.2014 | | Bristol-Myers Squibb SA | | | | | | | | | | | | | 07.16.40. | | | | 07.16.40. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Imnovid 1 mg | Hartkapseln | Capsules (Pomalidomidum 1 mg) | L04AX06 | CI | | 02 | Imnovid 2 mg | Hartkapseln | Capsules (Pomalidomidum 2 mg) | L04AX06 | CI | | 03 | Imnovid 3 mg | Hartkapseln | Capsules (Pomalidomidum 3 mg) | L04AX06 | CI | | 04 | Imnovid 4 mg | Hartkapseln | Capsules (Pomalidomidum 4 mg) | L04AX06 | CI |
|
|
|
